SciELO - Scientific Electronic Library Online

 
vol.87 issue5Intravitreal ranibizumab for choroidal neovascularisation associated with adult-onset vitelliform dystrophy author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Archivos de la Sociedad Española de Oftalmología

Print version ISSN 0365-6691

Abstract

GONZALEZ-GOMEZ, A.; MORILLO, M.J.; GONZALEZ-ESCOBAR, A.B.  and  GARCIA-CAMPOS, J.M.. Choroidal neovascularization secondary to pseudoxanthoma elasticum treated with ranibizumab: a report of 2 cases. Arch Soc Esp Oftalmol [online]. 2012, vol.87, n.5, pp.153-156. ISSN 0365-6691.

Case report: We report 2 cases of pseudoxanthoma elasticum with angioid streaks and choroidal neovascularization (CNV) in both eyes. Intravitreal ranibizumab (Lucentis) was administered with successful results in both cases. Discussion: CNV has been reported to occur in 72% to 86% of patients with angioid streaks. Although uncommon, the impact of CNV is important because it tends to affect people of working age. Based on the effectiveness of ranibizumab in other secondary CNVs, we decided to use it in our patients, observing the functional and anatomical improvement.

Keywords : Angioid streaks; Ranibizumab; Choroidal neovascularization; Pseudoxanthoma elasticum.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License